SURVEY: Costs of unannounced audits in EU not expected to be too high
This article was originally published in Clinica
Executive Summary
The introduction of unannounced visits by notified bodies in the EU is not expected to put too heavy a cost burden on medtech companies, according to a recent survey by Clinica.